lab-on-a-chip
Antelope Dx Completes €9M Series B Financing Round
The Belgian home testing company said it will use the money to initiate clinical development for a urine-based self-test for chlamydia and gonorrhea.
Antelope Dx Wins €2.2M Grant to Expand At-Home Diagnostic Technology
Antelope is currently developing a urine-based at-home test for the sexually transmitted infections Chlamydia trachomatis and Neisseria gonorrhoeae.
Accelmed Partners to Acquire TearLab, Invests $25M
The investment will be used to partially pay down TearLab's existing debt and fund growth opportunities for the ophthalmic diagnostic firm.
UK's DnaNudge Prepares Cartridge-Based PCR Test for COVID-19 Testing
The UK Department of Health and Social Care has already ordered 10,000 RNA test cartridges from the company, which expects to obtain a CE-IVD mark for its test within weeks.
DIAMONDS Project Using New Classification Approach to Develop Rapid Infectious Disease Tests
Premium
Technology partners on the study include BioMérieux and SkylineDx, as well as Imperial College London's biomedical electronics unit.
Oct 11, 2018
FDA Declines to Clear TearLab Dry-Eye Test
Apr 11, 2018
Allergy Dx Technology Deal Reached by ALK, Rellergen
Mar 23, 2018